Distribution and drug resistance analysis of pathogens in early-stage digestive tract perforation complicated with peritonitis

Distribution and drug resistance analysis of pathogens in early-stage digestive tract perforation complicated with peritonitis

Play all audios:

Loading...

ABSTRACT To investigate the distribution and drug resistance of pathogens associated with early-stage digestive tract perforation with peritonitis. A retrospective analysis was conducted on


patients with digestive tract perforation and peritonitis at Huadu District People’s Hospital of Guangzhou from Jan. 2020 to Aug. 2024. The selected patients were divided into two groups:


the upper digestive tract (UDT) group and the lower digestive tract (LDT) group. General clinical characteristics and intraoperative secretions culture results were compared and analyzed.


The study included 831 patients; 41.28% were in UDT group followed 58.72% in LDT group. 694 strains that isolated comprised 503 Gram-negative bacteria (GNB), 93 g-positive bacteria (GPB) and


98 fungi. Compared to LDT group, the UDT group had a higher positive rate of GPB and fungi but a lower positive rate of GNB. The most common pathogens among GNB were E.coli, Pseudomonas


aeruginosa, and Klebsiella pneumoniae; among GPB were Streptococcus anginosus, Enterococcus aviae, and Streptococcus constellations; among fungi were Candida albicans, Candida glabrata, and


Candida Cruxalis. We further analyzed drug susceptibility results to related antibacterial drugs. The findings from this study have significant implications for guiding initial empirical


antimicrobial therapy for patients with digestive tract perforation and peritonitis. SIMILAR CONTENT BEING VIEWED BY OTHERS ANTIBIOTIC SENSITIVITY IN CORRELATION TO THE ORIGIN OF SECONDARY


PERITONITIS: A SINGLE CENTER ANALYSIS Article Open access 29 October 2020 ANTIBIOTIC SELECTION BASED ON MICROBIOLOGY AND RESISTANCE PROFILES OF BILE FROM GALLBLADDER OF PATIENTS WITH ACUTE


CHOLECYSTITIS Article Open access 03 February 2021 ANTIMICROBIAL RESISTANCE SURVEILLANCE OF GRAM-NEGATIVE BACTERIA AMONG SOLID ORGAN TRANSPLANT RECIPIENTS, A 4-YEAR RETROSPECTIVE STUDY


Article Open access 03 June 2025 INTRODUCTION As defined by Sepsis-3, sepsis is life-threatening organ dysfunction caused by a dysregulated host response to serious infection1, which usually


progresses rapidly and leads to septic shock and multiple organ failure.Gastrointestinal perforation with peritonitis is a common acute abdominal disease and a frequent cause of sepsis and


septic shock, with a mortality rate ranging from 8 to 25%2,3. The prognosis of severe cases is influenced by age, with higher mortality rates being observed in the elderly population4. Early


and effective anti-infective therapy plays a crucial role in improving patient outcomes5. The increasing burden of antimicrobial resistance (AMR) poses a significant global health problem


at present. A recent systematic analysis in The Lancet estimated that 4.71 million deaths were associated with bacterial AMR, of which approximately one-quarter of deaths were attributed to


bacterial AMR6. Furthermore, the prevalence of AMR varies greatly across different regions and age groups6,7, particularly affecting the elderly population aged over 70 years who are


estimated to experience the highest proportion of drug-resistant related deaths in the future6. A multinational study involving 2,621 patients reported that the overall prevalence of AMR


among ICU patients with abdominal infections was 26.3%8. Moreover, the AMR was identified as one of the independent risk factors for mortality8. The rational use of antibiotics, saving lives


from infections, and reducing the occurrence of AMR remain ongoing challenges for clinicians. Therefore, regular monitoring and research on drug resistance are crucial. In this trial


conducted at Huadu District People’s Hospital in Guangzhou from January 2020 to August 2024, patients with digestive tract perforation and peritonitis were selected to compare and analyze


their general clinical characteristics and intraoperative secretion culture results. This study aims to understand pathogen distribution and drug resistance patterns, providing valuable


guidance for empirical antibiotic use. MATERIAL AND METHODS STUDY DESIGN Patients with digestive tract perforation and peritonitis were retrospectively selected from Huadu District People’s


Hospital of Guangzhou, for a single-center analysis, from January 2020 to August 2024. Only patients who underwent emergency surgical treatment and had the location of perforation identified


were included in this study. They were divided into two groups: the upper digestive tract (UDT) group and the lower digestive tract (LDT) group. The clinical characteristics collected for


statistical analysis included age, gender, perforation location, cause of perforation, blood culture results, secretion culture results from aseptic surgery, and drug sensitivity


information. This study was approved by the Ethics Committee of Huadu District People’s Hospital of Guangzhou (NO. 2025007), and written informed consent was obtained from all patients. All


methods were performed in accordance with the relevant guidelines and regulations. INCLUSION AND EXCLUSION CRITERIA Inclusion criteria: (1) Patients with peritonitis resulting from


digestive-tract perforation, including the esophagus, stomach, duodenum, gallbladder, pancreas, small intestine, ileocecal part, colon, and rectum; (2) Emergency surgical treatment was


performed and the site of perforation was identified. Exclusion criteria: (1) Age < 2 years; (2) Elective surgery or no surgery. STRAIN IDENTIFICATION AND SENSITIVITY The microbiological


samples (Table 1) obtained from patients during emergency aseptic surgeries were subjected to strain identification and sensitivity testing through secretion culture at the Laboratory of


Huadu District People’s Hospital. The VITEK® MS instrument (BioMerieux, France) and the VITEK-2 Compact Automated Antimicrobial Susceptibility Testing (AST) systems were utilized for species


identification and initial drug susceptibility testing. These systems automatically analyze and interpret the results. The generated report provides information on the species of bacteria


cultured, the Minimum Inhibitory Concentration (MIC) values of tested antibiotics for drug sensitivity (via microbroth dilution), or the inhibition zone diameter (via disc diffusion), along


with the corresponding sensitivity classification (e.g., sensitive, intermediate, drug resistant, etc.). For specific strains such as carbapenem-resistant Enterobacteriaceae (CRE), other


antibiotics like ceftazidime/avibactam may be included in the testing process. STATISTICAL ANALYSIS The collected data were subjected to statistical analysis using SPSS 19.0, with the


two-independent-sample t-test employed for measurement data and the Chi-square test used for enumeration data. Significance was determined by p values < 0.05 for two-tailed tests. RESULTS


831 patients that underwent the emergency surgery due to the perforation of digestive tract with peritonitis were included in this study. The UDT group (41.28%) accounted for 343 cases, age


of which was 54.90 \(\pm\) 18.29 (14 to 94); 81.34% were males and 18.66% females. The LDT group (58.72%) was with 488 cases; age of which was 40.85 \(\pm\) 17.86 (4 to 85); 65.78% were


males and 34.22% females. Compared with the LDT group, the proportion of males in the UDT group was statistically higher (81.31% vs. 65.78%, p < 0.001), and the average age was older (p


< 0.001). (Table 1). LOCATION Our study showed that, in the part of UDT perforation, the sources were most frequently located in stomach (56.85% of the patients) and duodenum (39.07%)


followed by esophagus (2.04%), gallbladder (1.74%), and pancreas (0.29%); in LDT, they mainly located at the ileocecal part (80.94%) followed by colon (9.43%), small intestine (8.20%) and


rectum (1.43%). (Table 1). CAUSE OF PERFORATION As our results, the most common cause of UDT perforation was gastric and duodenal ulcer, that of which occupied for 93.29% patients followed a


small number of cases in the injury of foreign bodies in the digestive tract (2.33%), infection (1.75%), tumor (1.75%), trauma (0.58%), and iatrogenic injury (0.29%). On the other hand, the


mainly cause of LDT was infection (78.89%) from both appendicitis and its’ involving infection of adjacent tissue, and the others were tumors (5.94%), diverticulum (4.92%), ulcers (2.25%),


trauma (1.43%), foreign body injury in digestive tract(1.43%), intestinal obstruction(1.23%), inguinal/internal hernia (0.82%) and iatrogenic injury (0.29%). Compared with the LDT group, the


proportion accounted in ulcer (93.29% vs.2.25%, p < 0.001) was significantly higher in UDT group, but that in infection (1.75% vs.78.89%, p < 0.001) and tumor (1.75% vs.5.94%, p =


0.005) was lower. There was no significant difference in the proportion of trauma, gastrointestinal foreign body injury or iatrogenic injury between the two groups. (Table 1). SPECIMEN


SUBMISSION In comparing with the LDT group, the rate of the blood culture submission in UDT group was significantly higher (20.70% vs.10.45%, p < 0.001); but that of the positive


secretions culture (42.73% vs.82.45%, p < 0.001)and the mixed- infection secretions (19.15% vs.33.59%, p = 0.002) was lower. There was no significant difference in the rate of positive


blood culture and secretion detection between groups.(Table 1). PATHOGEN DISTRIBUTION A total of 694 strains were isolated from secretions culture, 177 stains in UDT group and the other 517,


respectively, in LDT group. 72.48% strains were Gram-negative bacteria (GNB), when 13.40% was Gram-positive bacteria (GPB) and 14.12% fungi. Compared with LDT group, the positive rate of


GPB (20.34% vs.11.03%, p = 0.003) and fungi (52.54% vs.0.97%, p < 0.001) in UDT group was significantly higher; but that of GNB (27.12% vs.88.01%, p < 0.001) was lower. The most common


findings of GNB were E.coli (63.02%), Pseudomonas aeruginosa (PA) (13.92%) and Klebsiella pneumoniae(8.15%); that of GPB were Streptococcus anginosus (21.51%), Enterococcus avium (15.05%)


and Streptococcus constellations (13.98%); of fungi were Candida albicans (55.10%), Candida glabra (19.39%) and Candida clorunda (14.29%). (Table 2). ANTIMICROBIAL RESISTANCE MAIN


GRAM-NEGATIVE BACTERIA Overall 317 strains of E. coli were isolated from secretions culture, including 91 ESBL-positive, 8 multidrug-resistant organisms (MDROs) and 3 CRE. On the other hand,


41 strains of Klebsiella pneumoniae were isolated with 4 ESBL-positive but without MDROs/CRE. And both the ESBL-positive (χ2 = 5.751, _P_ = 0.016) and drug-resistant (ESBL+/MDROs/CRE)


strains (χ2 = 7.713, _P_ = 0.005) were accounted for a higher proportion in E. coli than in Klebsiella pneumoniae. Regarding AMR patterns, high levels of drug resistance in E.coli were


observed against cotrimoxazole, levofloxacin, as well as various cephalosporins such as cefuroxime, cefuroxime axetil and ceftriaxone (rates of resistance, 31.86% to 62.78%). On the other


hand, Klebsiella pneumoniae displayed only moderate resistance against these drugs (12.2%−14.63%). However, both E. coli and Klebsiella pneumoniae demonstrated higher sensitivity rates


towards carbapenems (99.05 and 100%), tigacycline (100%), cefoperazone-sulbactam (98.74% and 100%, respectively), amikacin(98.42% and100%), as well as piperacillin/tazobactam (94.64% and


95.12%). (Table 3). Furthermore, a total of 70 strains of PA that isolated from secretions cultures were without drug-resistant ones. Most antibacterial agents demonstrated higher


sensitivity against PA, including piperacillin/tazobactam, ceftazidime, cefoperazone/sulbactam, cefepime, imipenem, meropenem, amikacin and tobramycin (rates of sensitivity, 95.71% to 100%).


However, ticarcillin/clavulanate and levofloxacin displayed noticeable resistance rates (7.14% and 11.43%, respectively). Notably, the sensitivity rate of polymyxin against PA was only


1.43%, with an intermediate rate of 94.29%. MAIN GRAM-POSITIVE BACTERIA Twenty strains of Streptococcus anginosus were isolated, and they exhibited significant resistance to erythromycin and


clindamycin (40% and 60%, respectively). However, they showed sensitivity to levofloxacin, vancomycin, cefepime, and cefotaxime (95%−100%). Thirteen strains of Streptococcus constellatus


that isolated demonstrated high resistance rates to erythromycin and clindamycin (both 76.92%), but better sensitivity rates to levofloxacin, chloramphenicol, vancomycin, ceftriaxone,


ampicillin, and cefotaxime (92.31%−100%). Moreover, fourteen strains of Enterococcus aviae exhibited high resistance rates (28.57%−71.43%) to various antibiotics including penicillin,


ampicillin,gentamicin,and erythromycin; however they displayed excellent sensitivity rates to linezolid, teicoranin,vancomycin,and tigacycline(all 100%). FUNGUS The common fungi isolated


from secretions were combined into 54 strains of Candida tropicalis, 19 strains of Candida glabrata, and 14 strains of Candida creososa. Sensitivity results revealed that Candida tropicalis


exhibited high sensitivity rates (96.3%−100%) to flucytosine, fluconazole, itraconazole, and voriconazole; while Candida glabrata showed sensitivity to flucytosine and voriconazole (94.74%


and 100%). Only Voriconazole demonstrated sensitivity against Candida krusei (Table 4). DISCUSSION Perforation of digestive tract with peritonitis is a common cause of sepsis. Compared to


UDT, LDT perforation has higher morbidity and mortality rates. Early effective anti-infective treatment can reduce the mortality in critically ill patients5. The aim of this study was to


investigate the distribution and drug resistance of pathogens associated with gastrointestinal perforation and subsequent peritonitis, providing a basis for selecting early antibiotics for


patients in this area. A total of 831 cases were collected in this study including 343 cases in UDT group and 488 cases in LDT group. Notably, demographic differences were observed between


the two groups: the UDT group had a higher proportion of males and older individuals compared to the LDT group.The causes of perforation were varied, including infection, ulcer, tumor,


diverticula, intestinal obstruction, inguinal/internal hernia, trauma, injury from foreign bodies in the digestive tract, iatrogenic injury, and unknown causes. However, the distribution of


these causes varied significantly across different regions. In a clinical retrospective study published in Front Surg, it was observed that 350 patients with perforated peritonitis were


predominantly males at Darbhanga Medical College and Hospital in India. The most common causes of perforation were duodenal ulcer (50%), typhoid fever (20%), traumatic injury, appendicitis,


and tuberculosis9. In contrast, our study revealed that the largest proportion of cases involved appendicitis and adjacent infections (46.33%), followed by gastroduodenal ulcers (38.51%).


Tumors accounted for 4.21% of cases, while diverticulum accounted for 2.89%. Traumatic injuries were rare, and there were no reported cases of typhoid fever or tuberculosis. Compared with


LDT group, the UDT group had a higher incidence of ulcers but lower rates of infections and tumors. Interestingly, case reports on digestive tract perforation frequently mentioned foreign


body injuries such as chicken bones, fish bones, rabbit bones, toothpicks, magnet balls, etc.10,11,12,13,14,15Additionally, digestive tract perforation occasionally occurred as a


complication of certain diseases like mediastinal emphysema, Rapunzel syndrome, Ehlers-Danlos syndrome, Schönlein-Henoch disease, and Peutz-Jeghers syndrome16,17,18,19,20. The etiological


culture test is considered one of the most crucial diagnostic tests for infectious diseases, and positive blood/secretion cultures in patients with peritonitis and sepsis are typically


associated with a higher mortality risk21. In our study, a total of 694 strains were isolated from secretion cultures; 177 strains were identified in UDT group, while 517 strains in LDT


group, respectively; 72.48% belonged to GNB followed 13.40% GPB and 14.12% fungi.When comparing UDT to LDT results, the rates of positive culture findings, mixed infections, and GNB in the


LDT group were higher; but that of GPB and fungal infection were lower. GNB, such as E. coli, PA, and Klebsiella pneumoniae, and GPB, including Streptococcus anginosus, Enterococcus avium


and Streptococcus constellatus were identified as the primary pathogens. For fungi, Candida albicans, Candida glabrata, and Candida krusei were the predominant species. E. coli, a common


pathogen in gastrointestinal infections, is a significant contributor to mortality. It ranked second only to Staphylococcus aureus as the most prevalent cause of fatal peritoneal and


abdominal infections with 30.4% of E. coli-related deaths occurring through such infections, followed by bloodstream infections (25.1%)22. In our analysis of drug resistance of common GNB,


we observed a higher prevalence of ESBL-positive and drug-resistant strains of E. coli. The drugs exhibiting greater resistance were cotrimoxazole, quinolones, second-generation


cephalosporins and ceftriaxone. Conversely, carbapenems, tigacycline, cefoperazone sulbactam, amikacin, piperacillin and tazobactam demonstrated good sensitivity towards E. coli and


Klebsiella pneumoniae. Additionally, PA is also a common pathogen associated with infection and mortality rates22. Previous studies have indicated a low isolation rate of PA in abdominal


infections but a high incidence rate in intensive care units (ICUs)23. However, in our study, the positive culture rate for PA was found to be second only to that of E. coli among the most


prevalent GNB. In terms of PA resistance analysis,it still exhibited good sensitivity towards various antibiotics except polymyxin,and drug-resistant ones were rare. A cross-country


systematic analysis in 2019 within the Americas region revealed that bacterial resistance was linked to 569,000 deaths,E. coli, Klebsiella pneumoniae and PA being major pathogens7.


Therefore, in clinical practice,to reduce the risk of infection-related mortality,the initial selection of antibiotics should avoid those with high resistance and instead opt for antibiotics


demonstrating better sensitivity. As for the duration of antibacterial drug use,no conclusive evidence has been established5. The extent of severe abdominal infection’s AMR varies


significantly across different regions.The overall rate of bacterial drug resistance was 26.3%, with refractory GNB accounting for 4.3%8. Among GNB, carbapenems exhibited a higher resistance


rate compared to other antibiotics6. For the treatment of intraperitoneal infections caused by CRE, antimicrobial therapy focuses on antibacterial agents such as Tigacycline, Elacycline,


Ceftazidime/avibactam, as well as novel carbapenem/beta-lactamase inhibitors like Meropenem/vabobactam, Imipenem/cilastatin/relebactam24. The common GPB associated with abdominal infection


include streptococcus and Enterococcus25, among which enterococcus is associated with 30-day mortality in patients with severe abdominal infection26. However, there are variations in the


distribution of strains across different studies. Previous research indicated that Enterococcus faecalis was the most prevalent GPB associated with digestive tract perforation and


peritonitis27. In contrast, our study found Streptococcus anginosus, Enterococcus avium and Streptococcus constellatus to be the most common GPB. Erythromycin and clindamycin exhibited high


resistance against Streptococcus anginosus and Streptococcus constellation; therefore, they should be avoided clinically whenever possible. On the other hand, levofloxacin and vancomycin


demonstrated higher sensitivity when tested against all three bacteria. For Enterococcus aviae infections, linezolid, teicoplanin, vancomycin, and tigecycline were found to be ideal


treatment options with a 100% sensitivity rate. Patients with fungal peritonitis complicated by sepsis and septic shock have a higher mortality rate28, an increased risk of postoperative


complications, delayed postoperative recovery and longer hospital stays compared to those without it29. A serum 1.3-β-D-glucan level < 3.3 pg/ml and a peritoneal level < 45 pg/ml,


combined with a low peritonitis score (< 3), are associated with a lower likelihood of abdominal fungal infection, which helps avoid unnecessary treatment with antifungal drugs30. Our


study found that patients with UDT perforation complicated by peritonitis had a significantly higher positive rate(52.54% vs.0.97%, p < 0.001)for culture fungi in secretions during


operation. Candida species were the only fungi cultured from secretions, predominantly Candida albicans, Candida glabrata, and Candida krusei. In clinical practice, not all positive fungal


cultures require antifungal therapy; however appropriate antifungal therapy reduces the risk of death within 30 days for severe surgical abdominal candidiasis31. Echinocandin is recommended


as first-line treatment for aggressive candida infections in critically ill patients while fluconazole is used as preventive treatment28,32. Recent literature suggests adding amphotericin B


liposomes as another option for treating abdominal candida infections33. The results of fungal susceptibility testing demonstrated that common broad-spectrum antifungal drugs exhibited high


efficacy against the majority of Candida albicans strains, with the exception of Candida glabra and Candida cloris. Notably, voriconazole displayed sensitivity towards all these strains,


making it an optimal choice for initial treatment of abdominal fungal infections. According to the previous literature review and the results of this study, we prepared an antibiotic


selection strategy for early digestive tract perforation complicated with peritonitis. (Fig. 1). Our study had some limits. Firstly, it was a retrospective study conducted at a single


center, which involving a limited number of regions and cases. Consequently, it lacked diversity and was susceptible to selection bias, which might have affected the accuracy of the results.


Secondly, the specimens of secretions used in our study were extracted during early operations, excluding those re-examined during disease progression or prolongation. The collection of


late specimens may have better reflected the changes in strain and drug sensitivity caused by widespread and sustained use of antibacterial drugs as well as disease progression, thereby


providing greater guidance for treatment adjustments in later stages. Finally, efforts such as multi-center collaboration, expanding the sample size, and analyzing the long-term outcomes of


drug-resistant bacteria will be the critical directions for our future research. Conclusion: The findings of this study partially reflect the current distribution of pathogens and the


patterns of AMR and sensitivity in gastrointestinal perforation and peritonitis in the north of Guangzhou, China. These results are highly significant for guiding early empirical antibiotic


therapy. DATA AVAILABILITY All data that used or analysed during the current study are available from the corresponding author. REFERENCES * Singer, M. et al. The third international


consensus definitions for sepsis and septic shock (Sepsis-3). _JAMA_ 315, 801. https://doi.org/10.1001/jama.2016.0287 (2016). Article  CAS  PubMed  PubMed Central  Google Scholar  * Amini,


A. & Lopez, R. _Duodenal Perforation_. (Treasure Island (FL): StatPearls Publishing, Jan) (2024). * Yadav, D. & Garg, P. K. Spectrum of perforation peritonitis in delhi: 77 cases


experience. _Indian J. Surg_ 75, 133–137 (2013). Article  PubMed  Google Scholar  * Arvaniti, K. et al. Epidemiology and age-related mortality in critically ill patients with intra-abdominal


infection or sepsis: an international cohort study. _Int. J. Antimicrob. Agents_ 60, 106591. https://doi.org/10.1016/j.ijantimicag.2022.106591 (2022). Article  CAS  PubMed  Google Scholar 


* Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. _Intensive care Med._ 47, 1181–1247.


https://doi.org/10.1007/s00134-021-06506-y (2021). Article  PubMed  PubMed Central  Google Scholar  * Collaborators, G. A. R. Global burden of bacterial antimicrobial resistance 1990–2021: a


systematic analysis with forecasts to 2050. _Lancet (London, England)_ 404, 1199–1226 (2024). Article  Google Scholar  * collaborator, A. r. The burden of antimicrobial resistance in the


Americas in 2019: a cross-country systematic analysis. _Lancet regional health. Americas_ 25, 100561, https://doi.org/10.1016/j.lana.2023.100561 (2023). * Blot, S. et al. Epidemiology of


intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. _Intensive Care Med._ 45, 1703–1717.


https://doi.org/10.1007/s00134-019-05819-3 (2019). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hameed, T., Kumar, A., Sahni, S., Bhatia, R. & Vidhyarthy, A. K. Emerging


Spectrum of Perforation Peritonitis in Developing World. _Front. Surg._ 7, 50. https://doi.org/10.3389/fsurg.2020.00050 (2020). Article  PubMed  PubMed Central  Google Scholar  * Mačiulienė,


A. et al. Predictors of 30-Day In-Hospital mortality in patients undergoing urgent abdominal surgery due to acute peritonitis complicated with sepsis. _Med. Sci. Monitor : Int. Med. J. Exp.


Clinic. Res._ 25, 6331–6340. https://doi.org/10.12659/msm.915435 (2019). Article  Google Scholar  * Kanamalla, K., Salamone, F. J. & Vargas, J. (2021) Perforated sigmoid colon in the


setting of chicken bone ingestion and diverticulitis: A case report. _Ann. Med. Surg._ 68, 102650. https://doi.org/10.1016/j.amsu.2021.102650 (2012). Article  Google Scholar  * Kriegler, T.,


Majernik, J. & Ninger, V. Perforation of descending colon diverticulum by swallowed rabbit bone - A case report. _Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti_


100, 94–96 (2021). CAS  PubMed  Google Scholar  * Evola, G. et al. Accidentally ingested wooden toothpick, perforation of a sigmoid diverticulum and mimicking acute colonic diverticulitis:


A case report and literature review. _Int. J. Surg. Case Rep._ 104, 107945. https://doi.org/10.1016/j.ijscr.2023.107945 (2023). Article  PubMed  PubMed Central  Google Scholar  * Peyron, P.


A., Villard, C. & Baccino, E. Fatal bowel perforation caused by ingestion of high-powered magnets in a 6-year-old boy. _Int. J. Legal Med._ 138, 1659–1662.


https://doi.org/10.1007/s00414-024-03188-1 (2024). Article  PubMed  Google Scholar  * Yamashita, K. et al. A rare case of perforation of a colorectal tumor by a fish bone. _Clin. J.


Gastroenterol._ 15, 598–602. https://doi.org/10.1007/s12328-022-01622-8 (2022). Article  PubMed  Google Scholar  * de Oliveira, M. F. A. & Rodrigues, M. A. M. Peutz-Jeghers syndrome: an


unusual autopsy finding in pregnancy. _Autops. Case Rep._ 11, e2021279. https://doi.org/10.4322/acr.2021.279 (2021). Article  PubMed  PubMed Central  Google Scholar  * Alotaibi, A. E.,


AlAamer, O. H., Bawazeer, M. A. & Alzahrani, A. A. Gastric perforation leading to the diagnosis of classic Ehlers-Danlos syndrome: a case report. _J. Med. Case Rep._ 15, 537.


https://doi.org/10.1186/s13256-021-03108-6 (2021). Article  PubMed  PubMed Central  Google Scholar  * Sert, O. Z. Multiple small bowel perforation in a young adult female due to Rapunzel


Syndrome. _Ann. Italiani di Chirurgia_ 9, 1–4 (2020). Google Scholar  * Vasileva, A. V., Chakarov, I. & Chakarova, P. Modern diagnostic methods for early assessment of the abdominal


involvement in Schönlein-Henoch disease. _Folia Med._ 66, 73–79. https://doi.org/10.3897/folmed.66.e113993 (2024). Article  CAS  Google Scholar  * Pachowska, K. et al. Pneumomediastinum as a


complication of colon perforation - a case report. _Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego_ 47, 226–228 (2019). PubMed  Google Scholar  * Sim, J., Hong, S. S.,


Kwak, J. Y. & Jung, Y. T. Prediction of culture-positive sepsis and selection of empiric antibiotics in critically ill patients with complicated intra-abdominal infections: a


retrospective study. _Europ. J. Trauma Emergency Surg : official Publication Europ. Trauma Soc._ 48, 963–971. https://doi.org/10.1007/s00068-020-01535-6 (2022). Article  Google Scholar  *


Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. _Lancet (London, England)_ 400, 2221-2248,


https://doi.org/10.1016/s0140-6736(22)02185-7 (2022). * Chou, J., Knight, P. H. & Sawyer, R. G. Is the isolation of pseudomonas aeruginosa associated with outcomes from intra-abdominal


infection? no, but the receipt of an empiric anti-pseudomonal agent Is. _Surg. Infect._ 22, 675–679. https://doi.org/10.1089/sur.2020.396 (2021). Article  Google Scholar  * Fiore, M. et al.


Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae: Etiology and antibiotic treatment. _World J. Hepatol._ 12, 1136–1147.


https://doi.org/10.4254/wjh.v12.i12.1136 (2020). Article  PubMed  PubMed Central  Google Scholar  * Mehta, N. Y., Lotfollahzadeh, S. & Copelin, I. E. in _StatPearls_ (StatPearls


Publishing, Copyright © 2024, StatPearls Publishing LLC., 2024). * Morvan, A. C. et al. Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical


care-an analysis of the OUTCOMEREA database. _Critical care (London, England)_ 23, 307. https://doi.org/10.1186/s13054-019-2581-8 (2019). Article  PubMed  Google Scholar  * Wang, H., Liu,


X., Bi, H., Tang, Y. & Wang, D. Clinical analysis of septic shock caused by acute upper and lower gastrointestinal perforation. _Zhonghua wei zhong bing ji jiu yi xue_ 32, 943–946.


https://doi.org/10.3760/cma.j.cn121430-20200417-00312 (2020). Article  PubMed  Google Scholar  * Hasibeder, W. & Halabi, M. Candida peritonitis. _Minerva Anestesiol_ 80, 470–481 (2014).


CAS  PubMed  Google Scholar  * Nyumura, Y. et al. Pathophysiology and surgical outcomes of patients with fungal peritonitis from upper gastrointestinal tract perforation: a retrospective


study. _Surg. Today_ https://doi.org/10.1007/s00595-024-02851-9 (2024). Article  PubMed  Google Scholar  * Novy, E. et al. Combination of serum and peritoneal 1 3-beta-D-glucan can rule out


intra abdominal candidiasis in surgical critically ill patients: A multicenter prospective study. _Critical care (London England)._ 27, 470. https://doi.org/10.1186/s13054-023-04761-7


(2023). Article  PubMed  PubMed Central  Google Scholar  * Yan, T. et al. Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical


Patients with Intra-abdominal Candidiasis. _World J. Surg._ 44, 1459–1469. https://doi.org/10.1007/s00268-020-05380-x (2020). Article  ADS  PubMed  Google Scholar  * Pemán, J. et al. Jávea


consensus guidelines for the treatment of Candida peritonitis and other intra-abdominal fungal infections in non-neutropenic critically ill adult patients. _Rev. Iberoam. Micol._ 34, 130–142


(2017). Article  PubMed  Google Scholar  * Maseda, E. et al. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis. _Critical care (London, England)_ 27, 382.


https://doi.org/10.1186/s13054-023-04673-6 (2023). Article  PubMed  Google Scholar  Download references FUNDING This research was supported by the Key Discipline Project (Grant No.


YNZDXK202202, 2022–2025) of the Huadu District People’s Hospital and the Huadu District General Medical Research Special Project (Grant No. 23-HDWS-006), Guangzhou. AUTHOR INFORMATION


AUTHORS AND AFFILIATIONS * Department of Critical Care Medicine, Huadu District People’s Hospital, Guangzhou, Guangdong, China Shuxiang Wang & Shuwen Yao Authors * Shuxiang Wang View


author publications You can also search for this author inPubMed Google Scholar * Shuwen Yao View author publications You can also search for this author inPubMed Google Scholar


CONTRIBUTIONS S.W. and S.Y.designed the study. S.Y. collectted and assembled the data. S.W. and S.Y. proformed the statistical analysis and wrote the manuscript, and S.W. prepared table1-4.


All authors reviewed the manuscript. CORRESPONDING AUTHOR Correspondence to Shuxiang Wang. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ADDITIONAL


INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. RIGHTS AND PERMISSIONS OPEN ACCESS This


article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction


in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the


licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article


are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and


your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this


licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Wang, S., Yao, S. Distribution and drug resistance analysis of


pathogens in early-stage digestive tract perforation complicated with peritonitis. _Sci Rep_ 15, 17308 (2025). https://doi.org/10.1038/s41598-025-02543-5 Download citation * Received: 24


October 2024 * Accepted: 14 May 2025 * Published: 19 May 2025 * DOI: https://doi.org/10.1038/s41598-025-02543-5 SHARE THIS ARTICLE Anyone you share the following link with will be able to


read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing


initiative KEYWORDS * Digestive tract perforation * Peritonitis * Pathogen * Drug resistance